These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 34131243)

  • 1. Susceptibility of cyclin-dependent kinase inhibitor 1-deficient mice to rheumatoid arthritis arising from interleukin-1β-induced inflammation.
    Takashima Y; Hayashi S; Fukuda K; Maeda T; Tsubosaka M; Kamenaga T; Kikuchi K; Fujita M; Kuroda Y; Hashimoto S; Nakano N; Matsumoto T; Kuroda R
    Sci Rep; 2021 Jun; 11(1):12516. PubMed ID: 34131243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin-Dependent Kinase Inhibitor-1-Deficient Mice are Susceptible to Osteoarthritis Associated with Enhanced Inflammation.
    Kihara S; Hayashi S; Hashimoto S; Kanzaki N; Takayama K; Matsumoto T; Chinzei N; Iwasa K; Haneda M; Takeuchi K; Nishida K; Kuroda R
    J Bone Miner Res; 2017 May; 32(5):991-1001. PubMed ID: 28128866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-522 Modulated the Expression of Proinflammatory Cytokines and Matrix Metalloproteinases Partly via Targeting Suppressor of Cytokine Signaling 3 in Rheumatoid Arthritis Synovial Fibroblasts.
    Wang X; Si X; Sun J; Yue L; Wang J; Yu Z
    DNA Cell Biol; 2018 Apr; 37(4):405-415. PubMed ID: 29394098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of Synovial Inflammation and Tissue Destruction by Guanylate Binding Protein 5 in Synovial Fibroblasts From Patients With Rheumatoid Arthritis and Rats With Adjuvant-Induced Arthritis.
    Haque M; Singh AK; Ouseph MM; Ahmed S
    Arthritis Rheumatol; 2021 Jun; 73(6):943-954. PubMed ID: 33615742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor-interleukin-17 interplay induces S100A8, interleukin-1β, and matrix metalloproteinases, and drives irreversible cartilage destruction in murine arthritis: rationale for combination treatment during arthritis.
    Koenders MI; Marijnissen RJ; Devesa I; Lubberts E; Joosten LA; Roth J; van Lent PL; van de Loo FA; van den Berg WB
    Arthritis Rheum; 2011 Aug; 63(8):2329-39. PubMed ID: 21520013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FM0807 decelerates experimental arthritis progression by inhibiting inflammatory responses and joint destruction via modulating NF-κB and MAPK pathways.
    Zhang N; Liu Z; Luo H; Wu W; Nie K; Cai L; Tan S; Chen X; Huang Y; Liu J; Lv M; Zhang X; Fan Y; Lin Y; Ye S; Liu Y; Wu L; Xu J
    Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31431516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-6 and matrix metalloproteinase-1 are regulated by the cyclin-dependent kinase inhibitor p21 in synovial fibroblasts.
    Perlman H; Bradley K; Liu H; Cole S; Shamiyeh E; Smith RC; Walsh K; Fiore S; Koch AE; Firestein GS; Haines GK; Pope RM
    J Immunol; 2003 Jan; 170(2):838-45. PubMed ID: 12517948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyrrolidine dithiocarbamate, a NF-kappaB inhibitor, upregulates MMP-1 and MMP-13 in IL-1beta-stimulated rheumatoid arthritis fibroblast-like synoviocytes.
    Kim KS; Oh DH; Choi HM; Bang JS; Ryu CJ; Kim JH; Yoo MC; Yang HI
    Eur J Pharmacol; 2009 Jun; 613(1-3):167-75. PubMed ID: 19379726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ASC plays a role in the priming phase of the immune response to type II collagen in collagen-induced arthritis.
    Yamazaki H; Takeoka M; Kitazawa M; Ehara T; Itano N; Kato H; Taniguchi S
    Rheumatol Int; 2012 Jun; 32(6):1625-32. PubMed ID: 21331573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of chondrocyte-mediated cartilage destruction by S100A8 in experimental murine arthritis.
    van Lent PL; Grevers LC; Blom AB; Arntz OJ; van de Loo FA; van der Kraan P; Abdollahi-Roodsaz S; Srikrishna G; Freeze H; Sloetjes A; Nacken W; Vogl T; Roth J; van den Berg WB
    Arthritis Rheum; 2008 Dec; 58(12):3776-87. PubMed ID: 19035520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-1beta in irrigation fluid and mRNA expression in synovial tissue of the knee joint as therapeutic markers of inflammation in collagen antibody-induced arthritis.
    Chia WT; Yeh LT; Chen YW; Lee HS; Chang DM; Sytwu HK
    Dis Markers; 2009; 26(1):1-7. PubMed ID: 19242063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergy between adiponectin and interleukin-1β on the expression of interleukin-6, interleukin-8, and cyclooxygenase-2 in fibroblast-like synoviocytes.
    Lee YA; Choi HM; Lee SH; Yang HI; Yoo MC; Hong SJ; Kim KS
    Exp Mol Med; 2012 Jul; 44(7):440-7. PubMed ID: 22549135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage migration inhibitory factor: a mediator of matrix metalloproteinase-2 production in rheumatoid arthritis.
    Pakozdi A; Amin MA; Haas CS; Martinez RJ; Haines GK; Santos LL; Morand EF; David JR; Koch AE
    Arthritis Res Ther; 2006; 8(4):R132. PubMed ID: 16872482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-17 receptor deficiency results in impaired synovial expression of interleukin-1 and matrix metalloproteinases 3, 9, and 13 and prevents cartilage destruction during chronic reactivated streptococcal cell wall-induced arthritis.
    Koenders MI; Kolls JK; Oppers-Walgreen B; van den Bersselaar L; Joosten LA; Schurr JR; Schwarzenberger P; van den Berg WB; Lubberts E
    Arthritis Rheum; 2005 Oct; 52(10):3239-47. PubMed ID: 16200598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CDK7 inhibition suppresses rheumatoid arthritis inflammation via blockage of NF-κB activation and IL-1β/IL-6 secretion.
    Hong H; Zeng Y; Jian W; Li L; Lin L; Mo Y; Liu M; Fang S; Xia Y
    J Cell Mol Med; 2018 Feb; 22(2):1292-1301. PubMed ID: 29083085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scavenger receptor class A type I/II determines matrix metalloproteinase-mediated cartilage destruction and chondrocyte death in antigen-induced arthritis.
    van Lent PL; Hofkens W; Blom AB; Grevers L; Sloetjes A; Takahashi N; van Tits LJ; Vogl T; Roth J; de Winther MP; van den Berg WB
    Arthritis Rheum; 2009 Oct; 60(10):2954-65. PubMed ID: 19790077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NR1D1 modulates synovial inflammation and bone destruction in rheumatoid arthritis.
    Liu H; Zhu Y; Gao Y; Qi D; Zhao L; Zhao L; Liu C; Tao T; Zhou C; Sun X; Guo F; Xiao J
    Cell Death Dis; 2020 Feb; 11(2):129. PubMed ID: 32071294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Joint production of IL-22 participates in the initial phase of antigen-induced arthritis through IL-1β production.
    Pinto LG; Talbot J; Peres RS; Franca RF; Ferreira SH; Ryffel B; Aves-Filho JC; Figueiredo F; Cunha TM; Cunha FQ
    Arthritis Res Ther; 2015 Sep; 17(1):235. PubMed ID: 26330334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acid-sensing ion channel 3 deficiency increases inflammation but decreases pain behavior in murine arthritis.
    Sluka KA; Rasmussen LA; Edgar MM; O'Donnell JM; Walder RY; Kolker SJ; Boyle DL; Firestein GS
    Arthritis Rheum; 2013 May; 65(5):1194-202. PubMed ID: 23335302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.